Gagnon, M., Savard, M., Tran, T. M. H., Vincent, L., Moquin, A., Tremblay, P., . . . Gobeil, F. (2023, July). Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease. Molecules.
Chicago Style (17th ed.) CitationGagnon, Maxime, Martin Savard, Thi Minh Hue Tran, Laurence Vincent, Alexandre Moquin, Philippe Tremblay, Xavier Roucou, Yves Dory, and Fernand Gobeil. "Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease." Molecules Jul. 2023.
MLA引文Gagnon, Maxime, et al. "Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease." Molecules, Jul. 2023.